Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of sodium selenite in patients with coronary artery disease
IRCT20110123005670N28Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium selenite in coronary arteriosclerosis, sponsored by Tabriz University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
sodium selenite
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20110123005670N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110123005670N28.